cartcloseinfolockmenuplayplayplayplayadd to playlistremove from playlistplaylist
State of Possible 2024: Rewriting What is Possible

Featured in this panel are  

Abe Ceesay, CEO, Rapport Therapeutics

Emma Lees, Ph.D., Sr. Vice President of Research & Early Development, Bristol Myers Squibb

Jacob Petersen, SVP, Head of Global Nucelic Acid Therapies, Novo Nordisk

Stan Wang, MD, Ph. D., CEO & Founder, Thymmune Therapeutics  

Chris Garabedian, CEO, Xontogeny - Moderator